WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H584281
CAS#: 59-14-3
Description: Broxuridine, also known as Bromodeoxyuridine, is a nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.
Hodoodo Cat#: H584281
Name: Broxuridine
CAS#: 59-14-3
Chemical Formula: C9H11BrN2O5
Exact Mass: 305.99
Molecular Weight: 307.100
Elemental Analysis: C, 35.20; H, 3.61; Br, 26.02; N, 9.12; O, 26.05
Synonym: Broxuridine; Bromodeoxyuridine
IUPAC/Chemical Name: 5-Bromo-2'-deoxyuridine
InChi Key: WOVKYSAHUYNSMH-RRKCRQDMSA-N
InChi Code: InChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
SMILES Code: OC[C@@H]1[C@H](C[C@H](N2C(NC(C(Br)=C2)=O)=O)O1)O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 307.10 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Trussart C, Pirlot C, Di Valentin E, Piette J, Habraken Y. Melanoma antigen-D2 controls cell cycle progression and modulates the DNA damage response. Biochem Pharmacol. 2018 Jan 22. pii: S0006-2952(18)30035-2. doi: 10.1016/j.bcp.2018.01.035. [Epub ahead of print] PubMed PMID: 29371029.
2: Hendrickson ML, Zutshi I, Wield A, Kalil RE. Nestin Expression and In Vivo Proliferative Potential of Tanycytes and Ependymal Cells Lining the Walls of the Third Ventricle in the Adult Rat Brain. Eur J Neurosci. 2018 Jan 23. doi: 10.1111/ejn.13834. [Epub ahead of print] PubMed PMID: 29359828.
3: Yu Y, Wang Z, Sun D, Zhou X, Wei X, Hou W, Ding Y, Ma Y, Hou Y. miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6. Eur J Pharmacol. 2018 Jan 16. pii: S0014-2999(18)30023-2. doi: 10.1016/j.ejphar.2018.01.016. [Epub ahead of print] PubMed PMID: 29355560.
4: Bang WS, Kim KT, Seo YJ, Cho DC, Sung JK, Kim CH. Curcumin Increase the Expression of Neural Stem/Progenitor Cells and Improves Functional Recovery after Spinal Cord Injury. J Korean Neurosurg Soc. 2018 Jan;61(1):10-18. doi: 10.3340/jkns.2017.0203.003. Epub 2017 Dec 29. PubMed PMID: 29354231; PubMed Central PMCID: PMC5769840.
5: Tsuji M, Tanaka T, Nagashima R, Sagisaka Y, Tousen Y, Nishide Y, Ishimi Y, Ishimi Y. Effect of daidzein and equol on DNA replication in MCF-7 cells. J Biochem. 2018 Jan 15. doi: 10.1093/jb/mvy006. [Epub ahead of print] PubMed PMID: 29346578.
6: Li FX, Wang J, Ma YY. [CCN3 regulates the proliferation and apoptosis in periodontal ligament fibroblasts]. Shanghai Kou Qiang Yi Xue. 2017 Oct;26(5):504-509. Chinese. PubMed PMID: 29308511.
7: Estensoro I, Pérez-Cordón G, Sitjà-Bobadilla A, Piazzon MC. Bromodeoxyuridine DNA labelling reveals host and parasite proliferation in a fish-myxozoan model. J Fish Dis. 2017 Dec 19. doi: 10.1111/jfd.12765. [Epub ahead of print] PubMed PMID: 29265424.
8: Giri PK, Lu Y, Lei S, Li W, Zheng J, Lu H, Chen X, Liu Y, Zhang P. Pretreatment with minocycline improves neurogenesis and behavior performance after midazolam exposure in neonatal rats. Neuroreport. 2017 Dec 18. doi: 10.1097/WNR.0000000000000937. [Epub ahead of print] PubMed PMID: 29256977.
9: Liang HM, Geng LJ, Shi XY, Zhang CG, Wang SY, Zhang GM. By up-regulating μ- and δ-opioid receptors, neuron-restrictive silencer factor knockdown promotes neurological recovery after ischemia. Oncotarget. 2017 May 23;8(60):101012-101025. doi: 10.18632/oncotarget.18195. eCollection 2017 Nov 24. PubMed PMID: 29254142; PubMed Central PMCID: PMC5731852.
10: Zhou WJ, Yang HL, Chang KK, Meng Y, Wang MY, Yuan MM, Li MQ, Xie F. Human thymic stromal lymphopoietin promotes the proliferation and invasion of cervical cancer cells by downregulating microRNA-132 expression. Oncol Lett. 2017 Dec;14(6):7910-7916. doi: 10.3892/ol.2017.7260. Epub 2017 Oct 23. PubMed PMID: 29250181; PubMed Central PMCID: PMC5727586.
11: Shuang T, Fu M, Yang G, Wu L, Wang R. The interaction of IGF-1/IGF-1R and hydrogen sulfide on the proliferation of mouse primary vascular smooth muscle cells. Biochem Pharmacol. 2017 Dec 14. pii: S0006-2952(17)30721-9. doi: 10.1016/j.bcp.2017.12.009. [Epub ahead of print] PubMed PMID: 29248598.
12: Robertson BA, Rathbone L, Cirillo G, D'Eath RB, Bateson M, Boswell T, Wilson PW, Dunn IC, Smulders TV. Food restriction reduces neurogenesis in the avian hippocampal formation. PLoS One. 2017 Dec 6;12(12):e0189158. doi: 10.1371/journal.pone.0189158. eCollection 2017. PubMed PMID: 29211774; PubMed Central PMCID: PMC5718509.
13: Han NR, Moon PD, Ryu KJ, Kim NR, Kim HM, Jeong HJ. Inhibitory effect of naringenin via IL-13 level regulation on thymic stromal lymphopoietin-induced inflammatory reactions. Clin Exp Pharmacol Physiol. 2017 Nov 29. doi: 10.1111/1440-1681.12880. [Epub ahead of print] PubMed PMID: 29193236.
14: Li C, Zhang B, Zhu Y, Li Y, Liu P, Gao B, Tian S, Du L, Bai YL. Post-stroke Constraint-induced Movement Therapy Increases Functional Recovery, Angiogenesis, and Neurogenesis with Enhanced Expression of HIF-1α and VEGF. Curr Neurovasc Res. 2017 Nov 28. doi: 10.2174/1567202614666171128120558. [Epub ahead of print] PubMed PMID: 29189156.
15: Nguemeni C, McDonald MW, Jeffers MS, Livingston-Thomas J, Lagace D, Corbett D. Short- and Long-term Exposure to Low and High Dose Running Produce Differential Effects on Hippocampal Neurogenesis. Neuroscience. 2018 Jan 15;369:202-211. doi: 10.1016/j.neuroscience.2017.11.026. Epub 2017 Nov 22. PubMed PMID: 29175485.
16: Xu CH, Liu Y, Xiao LM, Guo CG, Zheng SY, Zeng EM, Li DH. Dihydroartemisinin treatment exhibits antitumor effects in glioma cells through induction of apoptosis. Mol Med Rep. 2017 Dec;16(6):9528-9532. doi: 10.3892/mmr.2017.7832. Epub 2017 Oct 19. PubMed PMID: 29152657.
17: Gao J, Bai H, Li Q, Li J, Wan F, Tian M, Li Y, Song Y, Zhang J, Si Y. In vitro investigation of the mechanism underlying the effect of ginsenoside on the proliferation and differentiation of neural stem cells subjected to oxygen-glucose deprivation/reperfusion. Int J Mol Med. 2018 Jan;41(1):353-363. doi: 10.3892/ijmm.2017.3253. Epub 2017 Nov 13. PubMed PMID: 29138802; PubMed Central PMCID: PMC5746305.
18: Das D, Bang S, Zhang S, Noh I. Bioactive Molecules Release and Cellular Responses of Alginate-Tricalcium Phosphate Particles Hybrid Gel. Nanomaterials (Basel). 2017 Nov 14;7(11). pii: E389. doi: 10.3390/nano7110389. PubMed PMID: 29135939; PubMed Central PMCID: PMC5707606.
19: Swanson MEV, Murray HC, Oliver MH, Waldvogel HJ, Firth EC, Curtis MA. Imposed running exercise does not alter cell proliferation in the neurogenic niches of young lambs. J Anim Sci. 2017 Oct;95(10):4381-4390. doi: 10.2527/jas2017.1710. PubMed PMID: 29108047.
20: Pandey H, Talukdar A, Gangte JS, Gupta SD, Chandra NC. Cholesterol homeostasis and cell proliferation by mitogenic homologs: insulin, benzo-α-pyrene and UV radiation. Cell Biol Toxicol. 2017 Nov 3. doi: 10.1007/s10565-017-9415-8. [Epub ahead of print] PubMed PMID: 29101605.